Back to Search
JAMES MCKIERNAN, MD
MD
Urology Physician
NPI: 1891804746IndividualAccepts Medicare
Specialties, Licenses & Credentials
Urology PhysicianPrimary
Urology
Code: 208800000X
202833(NY)
CMS Specialties
PrimaryUROLOGY
Education
COLUMBIA UNIVERSITY COLLEGE OF PHYSICIANS AND SURGEONS
Class of 1993
Research & Publications (20)
Phase I trial of intravesical docetaxel in the management of superficial bladder cancer refractory to standard intravesical therapy.
PMID 16809732·J Clin Oncol·2006
3-trial
Reoperative retroperitoneal surgery for nonseminomatous germ cell tumor: clinical presentation, patterns of recurrence, and outcome.
PMID 14550453·Urology·2003
8-other
Partial nephrectomy for renal cortical tumors: pathologic findings and impact on outcome.
PMID 12475658·Urology·2002
8-other
Natural history of chronic renal insufficiency after partial and radical nephrectomy.
PMID 12031359·Urology·2002
8-other
The number of negative pelvic lymph nodes removed does not affect the risk of biochemical failure after radical prostatectomy.
PMID 19549117·BJU Int·2010
8-other
Increasing detection rate of benign renal tumors: evaluation of factors predicting for benign tumor histologic features during past two decades.
PMID 19371933·Urology·2009
8-other
Zyflamend in men with high-grade prostatic intraepithelial neoplasia: results of a phase I clinical trial.
PMID 19476738·J Soc Integr Oncol·2009
3-trial
Reoperative retroperitoneal lymph-node dissection for testicular germ cell tumor.
PMID 19636565·World J Urol·2009
6-review
The relationship between preoperative prostate-specific antigen and biopsy Gleason sum in men undergoing radical retropubic prostatectomy: a novel assessment of traditional predictors of outcome.
PMID 18778352·BJU Int·2009
8-other
Robot-assisted radical cystoprostatectomy in complex surgical patients: single institution report.
PMID 19497175·Can J Urol·2009
8-other
A single-institution experience with induction and maintenance intravesical docetaxel in the management of non-muscle-invasive bladder cancer refractory to bacille Calmette-Guérin therapy.
PMID 19389012·BJU Int·2009
3-trial
Significant change in predicted risk of biochemical recurrence after radical prostatectomy more common in black than in white men.
PMID 19589568·Urology·2009
4-observational
The novel use of intravesical docetaxel for the treatment of non-muscle invasive bladder cancer refractory to BCG therapy: a single institution experience.
PMID 19214528·World J Urol·2009
8-other
Invasion of renal sinus fat is not an independent predictor of survival in pT3a renal cell carcinoma.
PMID 19154464·BJU Int·2009
8-other
Fear and loathing in the Caribbean: three studies of fear and cancer screening in Brooklyn's immigrant Caribbean subpopulations.
PMID 19208205·Infect Agent Cancer·2009
8-other
The case of a poorly differentiated gastric adenocarcinoma disguised as a testicular germ cell tumor in a 34-year-old male.
PMID 19679336·Urology·2009
5-case
How often do available preoperative risk factors accurately predict the risk assessed after surgery for localized prostate cancer?
PMID 18778341·BJU Int·2009
8-other
Barriers to the initiation and maintenance of prostate specific antigen screening in Black American and Afro-Caribbean men.
PMID 18930293·J Urol·2008
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 161 FORT WASHINGTON AVE, 11TH FLOOR
NEW YORK, NY 10032 - Phone
- (212) 305-0114
Quick Facts
- NPI
- 1891804746
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 33
- Publications
- 20
Are you this provider?
Claim Your Profile